ZIMLABORATORIES / guidance tracker

Keep management guidance in view.

Zim Laboratories · forward-looking guidance across the available source record.

Research layer active

Guidance tracker

What management said would happen.

EU GMP audit expected in Q1 FY27

Management expects the EUGMP audit to occur in April-June 2026, with most CAPA responses submitted.

other

NIP product revenue inflection post-EUGMP clearance

Once EUGMP is cleared, NIP product revenue could scale to ₹20 crore+ per quarter, with agreements already in place.

revenue

20% growth in emerging markets (ex-Bangladesh)

Management targets 20% growth in emerging markets excluding Bangladesh, driven by new hires and product registrations.

growth

Dedicated block for key product to be operational by March 2027

A separate manufacturing block for a high-potential product will be converted into a site by March 2027, with MA expected within months.

capex